ANGPT2 and neoplasm: Interestingly, our meta-analysis also indicated a trend of ANGPT2 upregulation across several cancer types, including colon, esophageal, glioblastoma, stomach, hepatocellular, and renal clear cell carcinomas, suggesting its involvement in tumour progression.